SVA
Sinovac Biotech, Ltd
SVA
SVA
Delisted
SVA was delisted on the 22nd of February, 2019.
37 hedge funds and large institutions have $118M invested in Sinovac Biotech, Ltd in 2017 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 10
Holders
37
Holding in Top 10
1
Calls
$266K
Puts
$217K
Top Buyers
| 1 | +$1.13M | |
| 2 | +$910K | |
| 3 | +$532K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$196K |
| 5 |
Goldman Sachs
New York
|
+$79K |
Top Sellers
| 1 | -$11.6M | |
| 2 | -$872K | |
| 3 | -$111K | |
| 4 |
CAM
ClariVest Asset Management
San Diego,
California
|
-$83K |
| 5 |
OAC
OMERS Administration Corp
Toronto,
Ontario, Canada
|
-$80K |